Tiotropium Bromide (Tiotropium Bromide) Patent Expiration, LOE Window & CMS Spending

Tiotropium Bromide (Tiotropium Bromide) by Lupin Pharmaceuticals: Multi-Source Generic Molecule, 1 AB generics, $121.4M 2024 CMS Part D & Medicaid spend.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorLupin Pharmaceuticals
FDA Application & PathwayReconciled (ANDA)
Exclusivity / Cliff HorizonMulti-Source Generic Molecule
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity DateNot listed / N/A
Orange Book Patents (*PED Extensions)0 patents (0 *PED)
Active AB-Rated Generic Competitors1
2024 CMS Total Public Spend$121.4M
2024 Medicare Part D Spend$97.0M
2024 Medicaid Spend$24.3M
Reported Wholesale Price Change (CA SB 17)0 statutory filings in 2023 to 2026 panel